2019
DOI: 10.1080/07391102.2019.1578264
|View full text |Cite
|
Sign up to set email alerts
|

Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, in silico docking and in vitro cytotoxicity analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 41 publications
0
16
0
Order By: Relevance
“…Addition of bromine to the furan‐chalcone 6c resulted in an efficient larvicidal compound with respect to its concentration, length of action and toxicity profile to other organisms. This substituent also effectively enhances the biological activity of other molecules 91–94 . Compared with compound 6d , compound 6c presented lower LC 50 and LC 90 values to kill Ae.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Addition of bromine to the furan‐chalcone 6c resulted in an efficient larvicidal compound with respect to its concentration, length of action and toxicity profile to other organisms. This substituent also effectively enhances the biological activity of other molecules 91–94 . Compared with compound 6d , compound 6c presented lower LC 50 and LC 90 values to kill Ae.…”
Section: Discussionmentioning
confidence: 96%
“…This substituent also effectively enhances the biological activity of other molecules. [91][92][93][94] Compared with compound 6d, compound 6c presented lower LC 50 and LC 90 values to kill Ae. aegypti (L3) larvae and had the advantage of not interfering with the growth of the four environmental indicator organisms.…”
Section: Discussionmentioning
confidence: 97%
“…Percentage of curcumin range from 2.85 to 6.5 %. [19,24,29,[33][34][35][36] Solvent for extraction using Soxhlet apparatus: Ethanol…”
Section: Major Active Constituent Api[28]mentioning
confidence: 99%
“…In this way, the molecular docking, a computational strategy that allows one to predict binding site complementarity between a drug and its therapeutic target, has been massively used to assist drug repositioning for several diseases [6] , [9] . For example, in silico simulations were used to evaluate non-nucleoside reverse transcriptase inhibitors for HIV treatment [10] , as well as currently used drugs against HIV-1 protease of subtype D [11] ; to study the substrate recognition processes for influenza drug targets [12] , [13] ; to investigate and screening inhibitors against Ebola virus [14] , [15] , [16] ; to explore potential binding pockets and inhibitors for Zika [17] , [18] , Chikungunya [19] and Dengue virus [20] , [21] ; to perform structure-based virtual screening studies of potential drug target of Leishmania donovani [22] ; to evaluate the anticancer activity of chloro and bromo-pyrazole curcumin knoevenagel condensates and phytoestrogens [23] , [24] ; to investigate the efficacy of direct acting antivirals (DAAs) to the treatment of different Hepatitis C virus [25] and to design modified peptidomimetic cellulose derivatives Hepatitis C virus protease inhibitors [26] . In addition, in silico simulationshave have also been used to evaluate potential inhibitors of the interaction between ACE2 and SARS-CoV-2 region binding domain [27] , to help in the drug repositioning of anti-Hepatitis C virus drugs [28] and anti-polymerase drugs [29] against SARS-CoV-2.…”
Section: Introductionmentioning
confidence: 99%